Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome

Published:2018-12-18 Issue:5 Volume:34 Page:855-863
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Maxted Andrew P.,Dalrymple Rebecca A.,Chisholm Denise,McColl John,Tse Yincent,Christian Martin T.,Reynolds Ben C.

Funder

University of Glasgow

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00467-018-4172-3.pdf

Reference32 articles.

1. Eddy AA, Symons JM (2003) Nephrotic syndrome in childhood. Lancet 362(9384):629–639

2. Özlü SG, Demircin G, Tökmeci N, Çaltık Yılmaz A, Aydoğ Ö, Bülbül M, Öner A (2015) Long-term prognosis of idiopathic nephrotic syndrome in children. Ren Fail 37(4):672–677

3. Kemper MJ, Valentin L, van Husen M (2017) Difficult-to-treat idiopathic nephrotic syndrome: established drugs, open questions and future options. Pediatr Nephrol 33(10):1641–1649

4. Karp AM, Gbadegesin RA (2016) Genetics of childhood steroid-sensitive nephrotic syndrome. Pediatr Nephrol 32(9):1481–1488

5. Kang HG, Cheong HI (2015) Nephrotic syndrome: what’s new, what’s hot? Korean J Pediatr 58(8):275–282

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of two and multiple doses of rituximab in pediatric patients with frequent relapses and steroid- dependent nephrotic syndrome. A single-center study;2024-05-13

2. Using real-world data to inform dosing strategies of rituximab for pediatric patients with frequent-relapsing or steroid-dependent nephrotic syndrome: a prospective pharmacokinetic-pharmacodynamic study;Frontiers in Pharmacology;2024-01-09

3. Repetitive doses of rituximab in childhood nephrotic syndrome prolong remission without a significant increase in side effects;Die Nephrologie;2023-04-27

4. Use of Rituximab in Childhood Idiopathic Nephrotic Syndrome;Clinical Journal of the American Society of Nephrology;2023-02-22

5. Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center;J BRAS NEFROL;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3